| 2.56 Delayed Data As of Jun 22 |  0.00 / 0.00%Today’s Change | 2.24 Today|||52-Week Range 4.25 | -36.16% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Cleveland Biolabs Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The median estimate represents a +1,462.50% increase from the last price of 2.56.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.
